FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claes Malm

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Maciej Machaczka; Claes Malm; Hamdy Omar; Mats Remberger; Ake Wahlin; Helene Hallböök; Jan-Erik Johansson; Gunnar Juliusson; Eva Kimby; Vladimir Lazarevic; Hans Hägglund
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
Bengt Simonsson; Marjatta Sinisalo; Anders Själander; Jesper Stentoft; Ulla Strömberg; Anders Almqvist; Ole Weiss Bjerrum; Mats Björeman; Hans Ehrencrona; Max Flogegård; Tobias Gedde-Dahl; Franz Gruber; Henrik Hjorth-Hansen; Veli Kairisto; Perttu Koskenvesa; Anders Lindblom; Claes Malm; Berit Markevärn; Satu Mustjoki; Kristina Myhr-Eriksson; Arnon Nagler; Johan Lanng Nielsen; Lotta Ohm; Karin Olsson; Kimmo Porkka; Anu Räsänen; Kari Remes; Fredrik Sandin
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia.
Magnus Björkholm; Asa Rangert Derolf; Charlotta Ekstrand; Lynn R Goldin; Fredrik Granath; Malin Hultcrantz; Sigurdur Y Kristinsson; Olle Linder; Claes Malm; Berit Markevärn; Lars Nilsson; Jan Samuelsson; Björn Andreasson; Gunnar Birgegård; Ola Landgren
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claes Malm (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Maciej Machaczka; Claes Malm; Hamdy Omar; Mats Remberger; Ake Wahlin; Helene Hallböök; Jan-Erik Johansson; Gunnar Juliusson; Eva Kimby; Vladimir Lazarevic; Hans Hägglund
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
Leukemia & lymphoma 2012;53(9):1699-705.
2011: Bengt Simonsson; Marjatta Sinisalo; Anders Själander; Jesper Stentoft; Ulla Strömberg; Anders Almqvist; Ole Weiss Bjerrum; Mats Björeman; Hans Ehrencrona; Max Flogegård; Tobias Gedde-Dahl; Franz Gruber; Henrik Hjorth-Hansen; Veli Kairisto; Perttu Koskenvesa; Anders Lindblom; Claes Malm; Berit Markevärn; Satu Mustjoki; Kristina Myhr-Eriksson; Arnon Nagler; Johan Lanng Nielsen; Lotta Ohm; Karin Olsson; Kimmo Porkka; Anu Räsänen; Kari Remes; Fredrik Sandin
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia.
Blood 2011;118(12):3228-35.
2011: Magnus Björkholm; Asa Rangert Derolf; Charlotta Ekstrand; Lynn R Goldin; Fredrik Granath; Malin Hultcrantz; Sigurdur Y Kristinsson; Olle Linder; Claes Malm; Berit Markevärn; Lars Nilsson; Jan Samuelsson; Björn Andreasson; Gunnar Birgegård; Ola Landgren
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(17):2410-5.
2006: Ulla Olsson-Strömberg; Mattias Höglund; Magnus Björkholm; Inger Braide; Kristina Carlson; Gösta Gahrton; Gunnar Grimfors; Robert Hast; Rickard Lerner; Olle Linder; Per Ljungman; Eva Löfvenberg; Claes Malm; Per-Gunnar Nilsson; Christer Paul; Stig Rödjer; Leif Stenke; Ulf Tidefeldt; Ingemar Turesson; Ann-Marie Uden; Ake Wahlin; Lars Vilen; Ingemar Winqvist; Olle Zettervall; Gunnar Oberg; Bengt Simonsson
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
Leukemia & lymphoma 2006;47(9):1768-73.
2006: Gunnar Juliusson; Niklas Theorin; Karin Karlsson; U Frödin; Claes Malm
Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival.
Bone marrow transplantation 2006;37(5):503-10.
2005: Bengt Simonsson; Gunnar Oberg; Mats Bjoreman; Magnus Bjorkholm; Jan Carneskog; Karin Karlsson; Gösta Gahrton; Gunnar Grimfors; Robert Hast; Hans Karle; Olle Linder; Per Ljungman; Johan Lanng Nielsen; Jonas Nilsson; Eva Lofvenberg; Claes Malm; Karin Olsson; Ulla Olsson-Stromberg; Christer Paul; Leif Stenke; Jesper Stentoft; Ingemar Turesson; Ann-Mari Udén; Ake Wahlin; Lars Vilén; Ole Weis-Bjerrum
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up.
Acta haematologica 2005;113(3):155-62.
2004: Ulla Olsson-Strömberg; Bengt Simonsson; Tomas Ahlgren; Magnus Björkholm; Karin Carlsson; Gösta Gahrton; Robert Hast; Eva Löfvenberg; Olle Linder; Per Ljungman; Claes Malm; Christer Paul; Stig Rödjer; Ingemar Turesson; Ann-Mari Udén; Ake Wahlin; Andreas Killander; Bengt Wadman; Jan Westin; Olle Vikrot; Olle Zettervall; Gunnar Oberg
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(6):462-6.
2003: Gunnar Juliusson; Karin Karlsson; Claes Malm; Ulla Frödin; Agneta Seger Mollén; Gerd Bäckström; Peter Söderkvist
Adjusted conditioning for allogeneic transplantation in a single center setting: mixed chimerism heralds relapse.
Leukemia & lymphoma 2003;44(4):669-79.
2002: Gunnar Juliusson; Karin Karlsson; Claes Malm
More potent graft-versus-myeloma effect than graft-versus-renal cell cancer effect.
Leukemia & lymphoma 2002;43(11):2233-4.
2002: Rolf Billström; Tomas Ahlgren; Albert N Békássy; Claes Malm; Tor Olofsson; Mattias Höglund; Felix Mitelman; Bertil Johansson
Acute myeloid leukemia with inv(16)(p13q22): involvement of cervical lymph nodes and tonsils is common and may be a negative prognostic sign.
American journal of hematology 2002;71(1):15-9.
2002: Ulla Axdorph; Leif Stenke; Gunnar Grimfors; Jan Carneskog; Jan Hansen; Olle Linder; Per Ljungman; Eva Löfvenberg; Claes Malm; Bengt Simonsson; Ingemar Turesson; Lars Vilén; Ann-Mari Udén; Magnus Björkholm
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase--a report from the Swedish CML Group.
British journal of haematology 2002;118(4):1048-54.
2002: Helene Hallböök; Bengt Simonsson; Tomas Ahlgren; Magnus Björkholm; Jan Carneskog; Gunnar Grimfors; Robert Hast; Karin Karlsson; Eva Kimby; Richard Lerner; Olle Linder; Mats Linderholm; Eva Löfvenberg; Claes Malm; Per-Gunnar Nilsson; Christer Paul; Leif Stenke; Dick Stockelberg; Ulf Tidefelt; Ingemar Turesson; Ann-Marie Uden-Blome; Lars Vilen; Ake Wahlin; Ingemar Winquist; Bengt Smedmyr
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia.
British journal of haematology 2002;118(3):748-54.
2002: Johan D Söderholm; Claes Malm; Gunnar Juliusson; Rune Sjödahl
Long-term endoscopic remission of crohn disease after autologous stem cell transplantation for acute myeloid leukaemia.
Scandinavian journal of gastroenterology 2002;37(5):613-6.
2000: Gunnar Juliusson; Fredrik Celsing; Ingemar Turesson; Stig Lenhoff; M Adriansson; Claes Malm
Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma.
British journal of haematology 2000;109(1):89-96.
1999: Bertil Johansson; Rolf Billström; Karin Broberg; Thoas Fioretos; Per-Gunnar Nilsson; Tomas Ahlgren; Claes Malm; B O Samuelsson; Felix Mitelman
Cytogenetic polyclonality in hematologic malignancies.
Genes, chromosomes & cancer 1999;24(3):222-9.
1997: Bertil Johansson; Rolf Billström; Ulf Kristoffersson; Måns Akerman; Stanislaw Garwicz; Tomas Ahlgren; Claes Malm; Felix Mitelman
Deletion of chromosome arm 3p in hematologic malignancies.
Leukemia 1997;11(8):1207-13.
1997: Rolf Billström; Bertil Johansson; Thoas Fioretos; Stanislaw Garwicz; Claes Malm; Olle Zettervall; Felix Mitelman
Poor survival in t(8;21) (q22;q22)-associated acute myeloid leukaemia with leukocytosis.
European journal of haematology 1997;59(1):47-52.
1996: Bengt Simonsson; Gunnar Oberg; M Björeman; Magnus Björkholm; Jan Carneskog; Gösta Gahrton; Robert Hast; H Karl; J Lanng-Nielsen; E Löfvenberg; Claes Malm; Ingemar Turesson; A M Udén; L Vilén; O Weis-Bjerrum
Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group.
Bone marrow transplantation 1996;17 Suppl 3():S63-4.
1996: Ioannis Panagopoulos; Pierre Aman; Bertil Johansson; Claes Malm; Stig Lenhoff; Rolf Billström; Felix Mitelman
NRAS mutations are rare in acute myeloid leukaemias with t(8;21) or inv(16).
European journal of haematology 1996;56(1-2):68-71.
1994: Bengt Simonsson; Gunnar Oberg; A Killander; M Björeman; Magnus Björkholm; Gösta Gahrton; Leif Stenke; Ingemar Turesson; A M Udén; Claes Malm
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-group.
Bone marrow transplantation 1994;14 Suppl 3():S55-6.
1993: Bengt Simonsson; Gunnar Oberg; A Killander; M Björeman; M Börkholm; Gösta Gahrton; Robert Hast; Ingemar Turesson; A M Udén; Claes Malm
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia.
Stem cells (Dayton, Ohio) 1993;11 Suppl 3():73-6.
1993: Thoas Fioretos; Per-Gunnar Nilsson; Pierre Aman; Sverre Heim; Ulf Kristoffersson; Claes Malm; Bengt Simonsson; Ingemar Turesson; Felix Mitelman
Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia.
Leukemia 1993;7(8):1225-31.
1991: Fredrik Mertens; B Sallerfors; Sverre Heim; Bertil Johansson; Ulf Kristoffersson; Claes Malm; Felix Mitelman
Trisomy 13 as a primary chromosome aberration in acute leukemia.
Cancer genetics and cytogenetics 1991;56(1):39-44.
1990: Fredrik Mertens; Bertil Johansson; Sverre Heim; Ulf Kristoffersson; Nils Mandahl; Ingemar Turesson; Claes Malm; A Othzén; C R Bartram; D Catovsky
Trisomy 14 in atypical chronic myeloid leukemia.
Leukemia 1990;4(2):117-20.
1988: Sverre Heim; Ulf Kristoffersson; Nils Mandahl; Claes Malm; Felix Mitelman
Variant translocation t(3;15)(q21;q22) in a patient with acute promyelocytic leukemia.
Leukemia 1988;2(1):65-7.